计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| F129560-1g |
1g |
现货 ![]() |
| |
| F129560-5g |
5g |
现货 ![]() |
| |
| F129560-25g |
25g |
现货 ![]() |
| |
| F129560-100g |
100g |
现货 ![]() |
|
| 别名 | 呋噻米 | 速尿 | 4-氯-N-呋喃基-5-氨磺酰邻氨基苯甲酸 | 5-(氨基磺酰基)-4-氯-2-([2-呋喃甲基]氨基)苯甲酸 | 呋喃苯胺酸 | 利尿磺胺 | 速尿灵 |
|---|---|
| 英文别名 | Diuzol | Furomen | Lasix | Radisemide | Salix | Urosemide | Furosan | Furose | Aldalix | Endural | Diural | Diurin | Lowpston | Seguril | Edemid | Uresix | Aluzine | Desdemin | Furodrix | Moilarorin | Urian | Frusemide | Frusenex | Furosemix | Novosemide |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Furosemide |
| 生化机理 | 呋塞米是一种 NKCC(Na+/2Cl-/K+)共转运体的襻利尿剂抑制剂。呋塞米是 GABAA 受体的非竞争性拮抗剂,对含α6 的受体的选择性比含α1 的受体高约 100 倍。环利尿剂。也是 GABA A 受体的非竞争性拮抗剂,对含 α6 受体的选择性比含 α1 受体高约 100 倍。 |
| 应用 | An inhibitor of NKCC and a GABAA receptor antagonist.Furosemide may also be used as a reference standard in determining the concentration of furosemide present in human urine samples using gas chromatography coupled with mass spectrometry (GC-MS). Furosemide may be used pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using diffuse reflectance spectroscopy. Furosemide may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by fluorimetry, spectrophotometry and high performance liquid chromatography (HPLC). These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 盐酸钠(钾)共转运体 2 抑制剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Furosemide is a loop diuretic inhibitor of NKCC (Na+/2Cl-/K+) cotransporter. Furosemide acts as a non-competitive antagonist at GABAA receptors with ~ 100-fold greater selectivity for α6-containing receptors than α1-containing receptors.An inhibitor of NKCC and a GABAA receptor antagonist. Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Furosemide is a diuretic drug, which finds a variety of therapeutic applications such as hepatic cirrhosis, cardiac insufficiency and arterial hypertension. Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Furosemide is classified under the group of loop diuretics. It is used for the prevention of hypertension linked to renal and cardiac insufficiency. |
| 纯度 | ≥98% |
| ALogP | 2 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504750672 |
|---|---|
| EC号 | 200-203-6 |
| 分子类型 | 小分子 |
| IIUPAC Name | 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid |
| INCHI | 1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19) |
| InChi Key | ZZUFCTLCJUWOSV-UHFFFAOYSA-N |
| Smiles | C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl |
| Isomeric SMILES | C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl |
| 分子量 | 330.74 |
| Reaxy-Rn | 840915 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=840915&ln= |
| 溶解性 | Soluble in DMSO (66 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), methanol (50 mg/ml), and DMF. |
|---|---|
| 敏感性 | 对光线敏感 |
| 分子量 | 330.740 g/mol |
| XLogP3 | 2.000 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 330.008 Da |
| 单同位素质量Monoisotopic Mass | 330.008 Da |
| 拓扑极表面积Topological Polar Surface Area | 131.000 Ų |
| 重原子数Heavy Atom Count | 21 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 481.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS08 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H360: 可能损害生育力或未出生的孩子 |
| 预防措施声明 |
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P308+P313: 如接触到或有疑虑:求医/就诊。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 |
| WGK Germany | 3 |
| RTECS | CB2625000 |
| 个人防护装备 | Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 | |
| 分析证书 | F129560 |
| 1. Guang-Rong Wu, Jia-Kun Xu, Li-Juan Sun, Ying-Fu Li, Shu-Qin Gao, Ying-Wu Lin. (2023) Application of engineered heme enzymes based on myoglobin with high peroxidase activity for efficient degradation of various emerging pollutants. Journal of Environmental Chemical Engineering, 11 (111471). [10.1016/j.jece.2023.111471] |
| 2. Haoyu Long, Yanhao Jiang, Yanjuan Liu, Yuefei Zhang, Wei Chen, Sheng Tang. (2023) Chromatographic separation performance of silica microspheres surface-modified with triazine-containing imine-linked covalent organic frameworks. TALANTA, 260 (124589). [PMID:37126925] [10.1016/j.talanta.2023.124589] |
| 3. Xueyan Gou, Fenglin Ran, Jinru Yang, Yanrong Ma, Xin’an Wu. (2022) Construction and Evaluation of a Novel Organic Anion Transporter 1/3 CRISPR/Cas9 Double-Knockout Rat Model. Pharmaceutics, 14 (11): (2307). [PMID:36365126] [10.3390/pharmaceutics14112307] |
| 4. Yuhua Zhang, Qiaojun Fang, Hongfeng Wang, Jieyu Qi, Shan Sun, Menghui Liao, Yunhao Wu, Yangnan Hu, Pei Jiang, Cheng Cheng, Xiaoyun Qian, Mingliang Tang, Wei Cao, Shang Xiang, Chen Zhang, Jianming Yang, Xia Gao, Zheng Ying, Renjie Chai. (2023) Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage. Autophagy, 19 (1): (75-91). [PMID:35471096] [10.1080/15548627.2022.2062872] |
| 5. Zhu Zaisheng, Xu Lingling, Liu Yujie, Wang Xiufang, Tian Yong. (2022) The synthesis of novel nanoparticles: transition from hollow to groove via self-template sacrifice strategy. JOURNAL OF POROUS MATERIALS, 29 (4): (1049-1059). [10.1007/s10934-022-01229-x] |
| 6. Jingxuan Qiu, Jing Lin, Chaoqun Zhang, Liping Zhao, Peng Wang, Jia Zhang, Rui Zhang, Yunchun Guo, Huiliang Wang. (2024) Solid-Liquid Equilibrium Behavior and Data Correlation of Furosemide in 12 Pure Solvents from 283.15 to 323.15 K. JOURNAL OF CHEMICAL AND ENGINEERING DATA, 69 (6): (2380-2390). [10.1021/acs.jced.4c00089] |